The Laboratory of Professor Vladimir Katanaev at the University of Geneva, Switzerland, is offering a one-year funded postdoctoral position in rare disease research. The research group focuses on molecular biology, protein biochemistry, and cell biology, with projects involving cloning, bacterial work, mammalian cell culture, and advanced cell assays such as Western blotting, immunofluorescence (IF), BRET, and luciferase assays. Experience with high-throughput screening (HTS) technologies is considered a strong plus for applicants.

The ideal candidate will have a strong background in molecular biology and protein biochemistry, with hands-on skills in relevant laboratory techniques. The position is open to candidates from Europe, who are strongly preferred, and will begin in early 2026. The postdoctoral researcher will join a dynamic team working on innovative projects related to rare diseases, contributing to the advancement of knowledge in this important area of medical science.

The University of Geneva provides a stimulating research environment, and the Katanaev Lab is known for its expertise in protein purification and cell and molecular biology. This opportunity is ideal for candidates seeking to further their research careers in rare disease biology and related biomedical fields.

Funding is provided for one year, but specific details regarding stipend or additional financial support are not mentioned. Interested candidates are encouraged to reach out to the laboratory or seek an introduction to Professor Katanaev for further application instructions. For more information, see the LinkedIn profiles provided.